Serious lymphocytic leukemia (CLL) is a lymphoid malignancy characterised with the proliferation and accumulation of mature CD5+ B cells during the blood, bone marrow and lymphoid tissues. The prognosis of CLL involves the presence of ≥five x109/L mono - clonal B cells of normal phenotype during the blood.Furthermore, lots of well set up adverse